- Evaxion shareholders will vote on a board-backed proxy proposal to amend the articles to expand authorization to issue warrants to directors, executives and key employees up to DKK 11.9 million in nominal share value, without pre-emptive rights.
- The same proposal would authorize related share capital increases up to DKK 11.9 million to implement warrant exercises, with exercise prices set at market price.
- Shareholders will also vote on a board proposal to authorize issuance of convertible loan notes convertible into shares up to DKK 73.5 million in nominal share value, without pre-emptive rights, with conversion at or near market price.
- The proposals are scheduled for a shareholder vote at the annual general meeting on 15 April 2026, and the board recommends approval.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Evaxion A/S published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001171843-26-001781), on March 19, 2026, and is solely responsible for the information contained therein.
Comments